Orlistat |
Xenical |
Image:Orlistat.png Orlistat Systematic (IUPAC) name 1-(3-hexyl-4-oxo-oxetan-2-yl)tridecan-2-yl 2-formylamino-4-methyl-pentanoate Identifiers CAS number 96829-58-2 ATC code A08AB01 PubChem 3034010 DrugBank APRD00255 Chemical data Formula C29H53NO5 Mol. weight 495.735 g/mol Pharmacokinetic data Bioavailability ? Metabolism ? Half life 1 to 2 hours. Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status S2(AU) POM(UK) ...
Wikipedia - [full article]
Orlistat Clinical Trials
- An RCT of Metformin Vs Orlistat in Obese Anovulatory Women
ClinicalTrials.gov Identifier: NCT00292799 - Recruiting
Anovulation; Obesity
- LOSS- Louisiana Obese Subjects Study
ClinicalTrials.gov Identifier: NCT00115063 - Active, not recruiting
Obesity
- Orlistat (Xenical) in the Treatment of Overweight Patients with Nonalcoholic Steatohepatitis (NASH)
ClinicalTrials.gov Identifier: NCT00160407 - Completed
Fatty Liver; Hepatitis
- The Effect of Xenical on Weight and Risk Factors
ClinicalTrials.gov Identifier: NCT00152360 - Recruiting
Obesity and obesity related pathology
- A Low-Carbohydrate, Ketogenic Diet versus Orlistat for Weight Loss
ClinicalTrials.gov Identifier: NCT00108524 - Completed
Obesity; Diabetes Mellitus
- Safety and Efficacy of Xenical in Children and Adolescents with Obesity-Related Diseases
ClinicalTrials.gov Identifier: NCT00001723 - Recruiting
Diabetes Mellitus; Hypertension; Metabolic Disease; Obesity; Sleep Apnea Syndrome
- Efficacy of MK0557 in Combination With Sibutramine or Orlistat
ClinicalTrials.gov Identifier: NCT00533481 - Completed
Obesity
- Orlistat Treatment of Crigler-Najjar Disease
ClinicalTrials.gov Identifier: NCT00461799 - Completed
Crigler-Najjar Syndrome
- Efficacy and Safety of ATL-962 in Obese Diabetics
ClinicalTrials.gov Identifier: NCT00156897 - Completed
Non-Insulin-Dependent Diabetes Mellitus; Obesity

Not Signed In -


